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SCIENTIFIC LETTERS
SHOE SIZE, STATURE AND CAESAREAN
DELIVERY
To the Editor: Van Bogaert's analyses of shoe size/ foot length'
and stature I.2 as indicators of pelvic (in)adequacy, assume that
their statistical relationships with caesarean delivery reflect
their allometric relationships with pelvic size. Yet caesarean
deliveries are the result of decisions taken by clinician(s)
responsible for assessing the risk (to mother and fetus) of
alternative delivery procedures, i.e. non-operative and/or
unassisted delivery. Anthropometric measurements (of height,
weight or shoe size) comprise only one component of the
information on which such decisions are based. These
measurements therefore have to compete with a variety of
additional maternal, fetal and social factors, many of which
influence the need (or desire) for operative delivery. For
example, older and primiparous mothers as well as those
experiencing gestational diabetes, pregnancy-induced
hypertension (Pili) or pre-eclampsia, have an increased risk of
caesarean delivery, as do mothers who have had one or more
previous caesarean deliveries. Likewise, macrosomia (birth
weight ~ 4 000 g), prematurity and (mal)presentation all
increase the risk of caesarean delivery, while the social identity
(class and ethnicity), negotiating skills and personal
preferences of both mothers and clinicians are likely to
influence their decision to undergo/undertake an operative
delivery.' To establish whether small shoe size or shorter
stature might increase the risk of caesarean delivery it is
therefore necessary to control for these potential (maternal,
fetal and social) confounders.
Using data abstracted from the obstetric notes of Birth-to-Ter
mothers who delivered at Chris Hani Baragwanath Hospital in
Soweto'.5 it was possible to assess whether small shoe size or
shorter stature were associated with an increased risk of
caesarean delivery both before and after controlling for a
number of alternative risk factors (maternal age, parity, body
mass index (BMI), previous caesarean delivery, Pili,
proteinuria, glycosuria, prematurity, macrosomia and fetal
sex). Obstetric notes were available for 539 of the 2 120 Birth-
to-Ten mothers who delivered at Baragwanath Hospital.'
Maternal shoe size had been recorded in the obstetric records
of 280 mothers, with height measurements available for 214 of
the 280. These anthropometric measurements were highly
correlated (Fig. 1) and, among this sample of mothers, height
explained more than three times as much variance in shoe size
Table I. Sociodemographic, anthropometric, obstetric and neonatal risk factors for caesarean delivery
Model 1 bivariate Model 2 multivariate Model 3 - multivariate Model 4 - multivariate
Risk factor (referent) N OR (95% Cl) OR (95%Cn N OR (95% Cl) N OR (95%Cn
Sociodemographic
Maternal age (20 - 29 y) 280
< 20 Y 0.94 (0.47, 1.86)
30 - 35 Y 1.03 (0.56, 1.88)
~36 Y 1.12 (0.48, 2.57)
Parity (not primiparous) 280 1.09 (0.67, 1.77)
Anthropometric
Body mass index
(26 - 29 kg/m') 214 205 205 205
< 26 kg/m' 1.63 (0.65, 4.08) 1.55 (0.60, 4.00) 1.50 (0.59, 3.85) 1.51 (0.58, 3.90)
> 29 kg/m' 3.16 (1.50, 6.66)t 2.79 (1.27, 6.11/ 3.00 (1.37, 6.61)t 2.98 (1.35, 6.61)t
Height (> 1.60 m) 214 205
1.51 - 1.60 m 1.35 (0.61, 2.98)
205
1.62 (0.67, 3.92) 1.48 (0.60, 3.62)
$1.50 m 1.57 (0.76, 3.22) 1.96 (0.88, 4.36)
Shoe size (~ size 7) 280 1.34 (0.76, 2.34)
1.62 (0.68, 3.85)
205 1.89 (0.89, 4.00) 205 1.60 (0.70, 3.62)
Obstetric
Previous caesarean (none) 269 2.00 (1.07, 3.74)' 205 2.71 (1.11,6.61)' 205 2.55 (1.06, 6.10)*
Pili (absent) 253 1.65, (0.91, 3.00)
205 2.72 (1.11, 6.67)*
Proteinuria (absent) 270 0.54 (0.20, 1.44)
IIIB
Glycosuria (absent) 269 0.43 (0.09, 2.17)
eonatal
Prematurity (~36 weeks) 276 0.48 (0.20, 1.13)
Macrosomia « 4 000 g) 280 8.50 (1.87, 38.8)t 205 4.08 (0.82, 20.34) 205 4.67 (0.93, 23.39)
Male fetal sex (female) 280 0.71 (0.44,1.14)
205 4.36 (0.86, 22.07)
'P < 0.05
tP < 0.01
OR =odds ratio; PIH =pregnancy-induced hypertension.
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Fig. 1. Scatter plot of maternalsh~esize ~gainst maternal height. The
solid line represents the relatIOnship predicted by the regressIOn: y =
14.0 (SEE 1.1) . x -16.3 (SEE 1.8); F =151.42, df =1 and 213, P <
0.001; adjusted r> = 0.41. The dotted lines represent the 95%
confidence intervals of the regression line.
(r> =0.41) as that observed in Van Bogaert's study (r> =0.12).'
evertheless, there was only a modest tendency towards an
increased risk of caesarean delivery for mothers with smaller
shoe sizes and those with shorter statures (model 1, Table I) -
even selecting those cut-offs for shoe size (below size 7) and
stature (below 1.60 m) that displayed the strongest bivariate
associations with caesarean delivery (analyses not shown). The
statistical strength of these associations did increase after
controlling for maternal and neonatal factors that were
significantly associated with an increased risk of caesarean
delivery (BMI, previous caesarean delivery and macrosomia;
models 2 and 3, Table 1), but none achieved statistical
significance (models 2, 3 and 4, Table I). Instead, caesarean
deliveries were up to three times mOTe common among
mothers who were obese (> 29 kg/m') before delivery, while
mothers who had already had at least one previous caesarean
delivery were more than twice as likely to have another.
These findings suggest that neither shoe size nor stature
were important (or useful) risk factors for caesarean delivery in
this population. Either they had a limited predictive value for
pelvic (in)adequacy, or they were perceived as irrelevant by
those deciding whether to perform a caesarean delivery. Given
that only half of the obstetric records examined in the present
study contained records of maternal shoe size, and fewer of
these also contained maternal height measurements, it is likely
that the clinicians responsible for collecting this information
share the view of the World Health Organistation (WHO)
I collaborative panel, which recently concluded that stature did11mD not meet the screening criteria for assisted delivery.>
George T H Ellison
Social Science Research Unit
Institute of Education
University of London
London
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PLANT STEROUSTEROLIN SUPPLEMENT USE IN
A COHORT OF SOUTH AFRICAN HIV-
INFECTED PATIENTS - EFFECTS ON
IMMUNOLOGICAL AND VIROLOGICAL
SURROGATE MARKERS
To the Editor: It has been demonstrated that micronutrient
supplementation m~y be an important prophylactic and
therapeutic measure for HIV-1-infected patients, and is
possibly one of the few potential interventions for low-income
countries.' In sub-Saharan countries facing the bulk of new
infections worldwide, the use of highly active antiretroviral
therapy (HAART) is out of reach of most patients because of
the cost in the private sector and the lack of provision of any
therapies by the health departments of these countries. In
recent years many groups have investigated the outcomes of
this infection in patients supplemented with vitamin B2 or
multivitamin supplementation including/excluding vitamin A
during pregnancy.' Some studies have shown that high doses
of vitamin B6 supplements were associated with improved
survival of patients, while zinc supplementation was associatec
with poorer survival.'
A supplement containing a mixture of plant sterols and
sterolins has been developed and investigated by our group in
the treatment of many diseases. This mixture has been shown
to have immune modulating activities - the addition of this
mixture to T-eells in vitro leads to the enhanced secretion of
interleukin 2 (IL2) and gamma interferon (INF_y)5~ and further
tests revealed that the mixture preferentially targets CD4 cells
of THl phenotype and leaves TH2 CD4 cells unaffected.' This
mixture was tested in a double-blind, placebo-eontroUed
manner as an adjuvant in patients with pulmonary tuberculosis
and it was shown to have a positive effect on disease recovery
in such patients.s The mixture was also tested in a double-
blind, placebo-eontrolled trial in healthy marathon runners
where it prevented exercise-induced inflammation and post-
event transient immune suppression! Furthermore, the
beneficial effects of this mixture in an animal model of
